Keystone Bio is a pioneering brand that brings together the fields of Biotech, Medicine, and Dentistry to combat systemic inflammation. Their team has made a groundbreaking discovery of a unique set of toxins released by Porphyromonas gingivalis (Pg) from the mouth into the bloodstream. These toxins drive inflammation throughout the body, disrupting the immune system and triggering various inflammatory diseases like dementia, early Alzheimer's, and cardio-metabolics.

Keystone Bio's mission is to advance therapeutics and companion diagnostics that specifically target Porphyromonas gingivalis (Pg) and halt the flow of these toxin-driven inflammations. By targeting the root cause of inflammatory diseases, Keystone Bio aims to eliminate specific virulent strains of Pg, an oral pathogen that secretes toxins and initiates inflammatory pathways in the body. Through their comprehensive pipeline of monoclonal antibody therapeutics and companion diagnostics, Keystone Bio aims to diagnose early, treat effectively, modify, prevent, and even reverse inflammation-driven diseases.

Their team consists of world-renowned experts in Pg, Alzheimer's, cardio-metabolic disease, and dentistry. With their cutting-edge research and innovative approach, Keystone Bio is taking a significant step towards addressing the root cause of inflammation-driven diseases and improving the lives of millions of people worldwide